The article examines the variety of linkages firms have established with university science. These include using universities as a source of ideas for start-ups, scientific collaboration between firms and laboratories, the role of scientists on the scientific advisory boards of firms, and the...

This paper discusses the introduction and implementation of ISO 9000 qualitystandards in the German and French car industry. Rather than a transfer of a set ofconcrete, well-understood rules, which are ready to be implemented, the paperargues, the quality standards have to be reconstructed and...

How are new forms of industrial organization accommodated into a country'slegal frameworks, and what effect does this have on the ability of firms toinnovate. Variations in the broad institutional organization of the German andUS political economies result in different processes of contract...

Can German national institutional frameworks be reconfigured to allow radical innovation in science-based industries? This paper examines the development of commercial technologies for entrepreneurial biotechnology start-up firms in Germany. During the 1980s and early 1990s an inadequate...

The German economy has widely been seen as failing to develop commercial innovation competencies necessary to compete in biotechnology, information technology, and other emerging new industries. Starting in the mid-1990s the German government has instituted a series of new technology policies...

The paper examines the relationship between supplier network organization and regional economic development. A distinctive feature of the German economy is theexistence of a large and productive base of small and medium companies,commonly called the Mittelstand. Chambers of Commerce, trade...

Using the case of the pharmaceutical industry, this paper assesses how the leading German and UK firms are adapting to changes in their competitive environment, at both the national and international level. We attempt to link how firms create governance structures (management decision-making,...

Using the case of the pharmaceutical industry, this paper assesses how the leading German and UK firms are adapting to changes in their competitive environment, at both the national and international level. We attempt to link how firms create governance structures (management decision-making,...

Innovative firms face two major kinds of risks in developing new technologies: competence destruction and appropriability. High levels of technical uncertainty and radical changes in knowledge in some fields generate high technical failure risks and make it difficult to plan research and...